At 1pm ET on December 14, 2022, LSPedia will hold an industry meeting to provide an overview of the LSPedia DSCSA Exceptions Pilot, covering its objectives, methodology for measurement, error categories, proposed resolutions, and process for error correction.
On Nov. 27, 2023, the last milestone of DSCSA’s 10-year phased requirements will go into enforcement. The 2023 milestone includes two major requirements: Interoperability and Enhanced Supply Chain Security (ESCS). The Exceptions Pilot is designed and structured to categorize, measure, and resolve errors and discrepancies surrounding Interoperability and Enhanced Security.
Discrepancies between physical product and EPCIS data will escalate sharply as more trading partners begin exchanging data in the coming year. Trading partners across the prescription drug supply chain will need both the ability to easily spot problems and a proven, tested playbook for what to do when they occur.
The Exceptions Pilot is designed to give participants valuable insight into what types of errors to expect, how to resolve them, and how to structure internal processes to prevent them from occurring in the first place.
Current participants include:
Fresenius Kabi, Kowa, ProficientRx, Westminster
AmerisourceBegen ICS, Kuehne+Nagel
CardinalHealth, Drogueria Betances, Oak Drugs, Quality Care Products, South Pointe, Vet4U Rx
Associated Food Stores, SpartanNash, Uptown Pharmacy
Manufacturers, 3PLs, wholesale distributors, dispensers, and healthcare providers are qualified to participate. We are seeking two more companies in each trading partner type to be part of the pilot program.
Follow this link to apply!
We recommend key stakeholders in the following roles to join this important industry event.
Register here for free.